Lombard Medical Technologies (LSE:LMT) Additional Paid-In Capital : £47.47 Mil(As of Dec. 2012)

View and export this data going back to . Start your Free Trial

What is Lombard Medical Technologies Additional Paid-In Capital?

Lombard Medical Technologies's quarterly additional paid-in capital increased from Dec. 2010 (£36.71 Mil) to Dec. 2011 (£47.30 Mil) and increased from Dec. 2011 (£47.30 Mil) to Dec. 2012 (£47.47 Mil).

Lombard Medical Technologies's annual additional paid-in capital increased from Dec. 2010 (£36.71 Mil) to Dec. 2011 (£47.30 Mil) and increased from Dec. 2011 (£47.30 Mil) to Dec. 2012 (£47.47 Mil).

Lombard Medical Technologies Additional Paid-In Capital Historical Data

The historical data trend for Lombard Medical Technologies's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lombard Medical Technologies Additional Paid-In Capital Chart

Lombard Medical Technologies Annual Data

Trend

Sep02

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Additional Paid-In Capital

Get a 7-Day Free Trial

37.18

38.14

36.71

47.30

47.47

Lombard Medical Technologies Semi-Annual Data
	Sep02	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12
Additional Paid-In Capital	Get a 7-Day Free Trial					37.18	38.14	36.71	47.30	47.47

Lombard Medical Technologies Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Lombard Medical Technologies Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Lombard Medical Technologies's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Lombard Medical Technologies (LSE:LMT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lombard Medical Technologies PLC (LSE:LMT) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.lombardmedical.com

Lombard Medical Technologies PLC is engaged in the design and development of endovascular stent grafts, their manufacture, and commercialization either directly through the group's own sales force or through a network of local distributors supported by clinical specialists from Lombard Medical. The principal product, the AorfixT AAA stent graft has European CE mark approval for use in patients with high-angle-neck aneurysms of up to 90 degrees. The group has operations in United Kingdom and United States of America.